EGFR and adenocarcinoma: A549 is an adenocarcinoma cell line that contains a wild-type EGFR and mutant KRAS. To generate an A549 EGFR knockout cell lines, a CRISPR/Cas9 approach was applied using three gRNAs targeting exons 2 and 3 of EGFR (Table S1).